Highlights
- Transdermal patches in psychiatry are available for selegiline, nicotine, buprenorphine, methylphenidate, rotigotine, and rivastigmine.
- Currently, there are no approved transdermal antipsychotics but clinical research on asenapine and aripiprazole patches are ongoing.
- Dermal reactions with patches include redness, itchiness, and rarely, serious dermal reactions.
- Pharmacokinetics are slower with transdermal patches including a lower peak plasma concentration.
Transcript
Hello! I’m Dr. Wegdan Rashad and you are listening to the Psychopharmacology Institute podcast. Psychopharmacology Institute is an independent, educational platform that aims to help you, the mental health clinician, prescribe even better!
This podcast is here to do just that, every two weeks we cover interesting and clinically relevant topics that you can apply right away in your practice.
Unlock this Podcast and earn
Become a Bronze, Silver, Gold, Bronze extended, Silver extended or Gold extended Member.
Already have an account? Sign in
